A variety of enzyme immunoassays (EIA) have become available for the diagnosis of Chlamydia trachomatis infections in clinical specimens. EIAs vary in specificity and sensitivity depending on the site from which the specimen is taken, and the prevalence of C trachomatis in the clinic from which samples are received. They remain attractive techniques because they are fast, ideally suited to processing large numbers of specimens, and amenable to automisation. One recurrent problem in the use of EIAs for the diagnosis of chlamydial infections has been that a wide variety of organisms (both Gram positive and Gram negative bacteria and viruses) may 
